Cannabinoid CB1 receptor knockout mice fail to self-administer morphine but not other drugs of abuse

被引:214
|
作者
Cossu, G
Ledent, C
Fattore, L
Imperato, A
Böhme, GA
Parmentier, M
Fratta, W
机构
[1] Univ Cagliari, Bb Brodie Dept Neurosci, I-09124 Cagliari, Italy
[2] Free Univ Brussels, IRIBHN, B-1070 Brussels, Belgium
[3] Rhone Poulenc Rorer SA, Ctr Rech Vitry Alfortville, F-94403 Vitry Sur Seine, France
关键词
CB1; receptor; CB1 receptor knockout mice; intravenous self administration; morphine; cocaine; amphetamine; nicotine; reward;
D O I
10.1016/S0166-4328(00)00311-9
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
The rewarding effects of morphine, cocaine, amphetamine and nicotine were evaluated in CB1 receptor knockout mice by means of an intravenous self-administration model. Experiments were carried out on drug-naive animals using a nose-poking response (NPR)-like as operandum. The results of the present study indicate that morphine did not induce intravenous self-administration in mutant CB1 receptor knockout mice, whereas it was significantly self-administered by the corresponding wild type mice. On the contrary, cocaine, amphetamine and nicotine were self-administered to the same extent by both wild type and CB1 receptor knockout mice. These data clearly indicate that the CB1 cannabinoid receptor is essential not only for the expression of cannabinoid reinforcing effects but also for the modulation of morphine rewarding effects. The specificity of such interaction is supported by the finding that contrary to morphine, cocaine, d-amphetamine and nicotine were self-administered by mice at the same extent either in presence or in absence of the CB1 receptor. (C) 2001 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:61 / 65
页数:5
相关论文
共 50 条
  • [41] Modulation of anxiety by acute blockade and genetic deletion of the CB1 cannabinoid receptor in mice together with biogenic amine changes in the forebrain
    Thiemann, Gunnar
    Watt, Carly A.
    Ledent, Catherine
    Molleman, Areles
    Hasenoehrl, Ruediger U.
    BEHAVIOURAL BRAIN RESEARCH, 2009, 200 (01) : 60 - 67
  • [42] Attenuation of basal and cocaine-enhanced locomotion and nucleus accumbens dopamine in cannabinoid CB1-receptor-knockout mice
    Xia Li
    Alexander F. Hoffman
    Xiao-Qing Peng
    Carl R. Lupica
    Eliot L. Gardner
    Zheng-Xiong Xi
    Psychopharmacology, 2009, 204
  • [43] Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats
    He, Xiang-hu
    Jordan, Chloe J.
    Vemuri, Kiran
    Bi, Guo-hua
    Zhan, Jia
    Gardner, Eliot L.
    Makriyannis, Alexandros
    Wang, Yan-lin
    Xi, Zheng-xiong
    ACTA PHARMACOLOGICA SINICA, 2019, 40 (03) : 365 - 373
  • [44] Comparison of the D2 Receptor Regulation and Neurotoxicant Susceptibility of Nigrostriatal Dopamine Neurons in Wild-Type and CB1/CB2 Receptor Knockout Mice
    Simkins, Tyrell J.
    Janis, Kelly L.
    McClure, Alison K.
    Behrouz, Bahareh
    Pappas, Samuel S.
    Lehner, Andreas
    Kaminski, Norbert E.
    Goudreau, John L.
    Lookingland, Keith J.
    Kaplan, Barbara L. F.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2012, 7 (03) : 533 - 538
  • [45] CB1 receptor knockout mice display reduced ethanol-induced conditioned place preference and increased striatal dopamine D2 receptors
    Houchi, H
    Babovic, D
    Pierrefiche, O
    Ledent, C
    Daoust, M
    Naassila, ML
    NEUROPSYCHOPHARMACOLOGY, 2005, 30 (02) : 339 - 349
  • [46] Altered dopamine D1 and D2 receptor mRNA expression in mesencephalon from mice exposed to repeated treatments with methamphetamine and cannabinoid CB1 agonist methanandamide
    Landa, Leos
    Jurajda, Michal
    Sulcova, Alexandra
    NEUROENDOCRINOLOGY LETTERS, 2012, 33 (04) : 446 - 452
  • [47] Local pretreatment with the cannabinoid CB1 receptor antagonist AM251 attenuates methamphetamine intra-accumbens self-administration
    Rodriguez, Jesse S.
    Boctor, Sherin Y.
    Flores, Luke C.
    Phelix, Clyde F.
    Martinez, Joe L., Jr.
    NEUROSCIENCE LETTERS, 2011, 489 (03) : 187 - 191
  • [48] Effect of the cannabinoid CB1 receptor antagonist SR-141716A on ethanol self-administration and ethanol-seeking behaviour in rats
    Daina Economidou
    Laura Mattioli
    Carlo Cifani
    Marina Perfumi
    Maurizio Massi
    Vincenzo Cuomo
    Luigia Trabace
    Roberto Ciccocioppo
    Psychopharmacology, 2006, 183 : 394 - 403
  • [49] Antidiabetic effects of sub-chronic administration of the cannabinoid receptor (CB1) antagonist, AM251, in obese diabetic (ob/ob) mice
    Irwin, Nigel
    Hunter, Kerry
    Frizzell, Nonna
    Flatt, Peter R.
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2008, 581 (1-2) : 226 - 233
  • [50] Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: Experiments with self-administration and brain-stimulation reward in rats
    Xi, Zheng-Xiong
    Spiller, Krista
    Pak, Arlene C.
    Gilbert, Jeremy
    Dillon, Christopher
    Li, Xia
    Peng, Xiao-Qing
    Gardner, Eliot L.
    NEUROPSYCHOPHARMACOLOGY, 2008, 33 (07) : 1735 - 1745